This list is for the codes only. Use this list to give to the IT programmers. The long version has additional explanations and notes for many of the codes.

These tables are also available in a printable version (PDF, 572 KB).

Comprehensive ICD-10 Casefinding "Must Collect" Code List for Reportable Tumors (Effective Date: 1/1/2011)

ICD-10 Code^ Explanation of Code
B21._ Human Immunodeficiency virus [HIV] disease with malignant neoplasms
C00._ – C97._ Malignant neoplasms
D00._ – D09._ In-situ neoplasms
D18.0 Hemangioma, any site
D18.1 Lymphangioma, any site
D32._ – D33._ Benign neoplasm of meninges (cerebral, spinal and unspecified), brain and other parts of central nervous systems
D35.2 – D35.4 Benign neoplasm of pituitary gland, craniopharyngeal duct, pineal gland
D39.0 Neoplasm of uncertain behavior uterus
D42._ – D43._ Neoplasm of uncertain or unknown behavior of meninges, brain and central nervous system
D44.3 – D44.5 Neoplasm of uncertain or unknown behavior of pituitary gland, craniopharyngeal duct and pineal gland
D45._ – D46._ Polycythemia vera, Refractory anemia
D47.1, D47.3, D47.7, D47.9 Other neoplasms of uncertain or unknown behavior of lymphoid, hematopoietic, and related tissue
D48.9 Neoplasm of uncertain or unknown behavior, unspecified
D76.0 Langerhans cell histiocytosis, not elsewhere classified

NOTE: Cases with these codes should be screened as registry time allows. These are neoplasm-related secondary conditions for which there should also be a primary diagnosis of a reportable neoplasm. Experience in the SEER registries has shown that using the supplementary list increases casefinding for benign brain and CNS, hematopoietic, and other reportable neoplasms.

Supplementary List: ICD-10 Code List to Screen For Cancer Cases Not Identified by Other Codes (Effective Date: 1/1/2011)

ICD-10 Code^ Explanation of Code
B20._, B22._, B23._, B24._ Human immunodeficiency virus [HIV] disease
B99 Other infectious diseases (Human papillomavirus, Retrovirus-HTLV types I, II and 2)
D10._ – D41._, D44._ Benign neoplasms (except for D32, D33, D35.2 D35.4) and neoplasms of uncertain or unknown behavior (except for D39.0, D42, D43, D44.3 D44.5)
D47.0, D47.2 Other neoplasms of uncertain or unknown behavior of lymphoid, hematopoietic, and related tissue
D48._ Neoplasms of uncertain or unknown behavior
D60._, D61._, D64._ Aplastic anemias and other anemias (except for D61.0)
D70._ Agranulocytosis
D72.1 Eosinophilia
D75.0 Familial erythrocytosis (familial polycythemia)
D75.8 Other specified diseases of blood and blood forming organs
D76.1 – D76.3 Certain diseases involving lymphoreticular tissue and reticulohistiocytic system
D80.0 – D80.1, D80.3 – D80.5 Immunodeficiency with predominantly antibody defects
D81._ Combined immunodeficiencies (except for D81.3, D81.5)
D82.0 Wiskott-Aldrich syndrome
D83._ Common variable immunodeficiency with predominant abnormalities of B-cell numbers and function
D84.1, D84.9 Other immunodeficiencies
D89._ Other disorders involving the immune mechanism, not elsewhere classified
E22.2 Syndrome of inappropriate secretion of antidiuretic hormone
E30.8 Other disorders of puberty
E31.9 Polyglandular dysfunction, unspecified
E34.0 – E34.1, E34.8 Other endocrine disorders
E83.5 Disorders of calcium metabolism
E88.0, E88.8 – E88.9 Other metabolic disorders
G04.8 Other encephalitis, myelitis, and encephalomyelitis
H55 Nystagmus and other irregular eye movements
J90 Pleural effusion, not elsewhere classified
K12.1 Other forms of stomatitis
K31.7 Polyp of stomach and duodenum
L30.4 Erythrema intertrigo
L53.8 Other specified erythematous conditions
L83 Acanthosis nigricans
L88 Pyoderma gangrenosum
M33.2 Polymyositis
M33.9 Dermatopolymyositis, unspecified
M35.9 Systemic involvement of connective tissue, unspecified
M84.4 Pathologic fracture, not elsewhere classified
O01._ Hydatidiform mole
Q85.0 Neurofibromatosis (nonmalignant) (9540/1)
Q90._ Down's syndrome
R18 Ascites
R52.9 Pain, unspecified
R59._ Enlarged lymph nodes
R85.6 Abnormal findings in specimens from digestive organs and abdominal cavity, abnormal cytological findings
R87.6 Abnormal findings in specimens from female genital organs, abnormal cytological findings.
T45.1 Poisoning by antineoplastic and immunosuppressive drugs
T66 Unspecified effects of radiation
T80.2, T80.8 Complications following infusion, transfusion, and therapeutic injection
Y43.1 – Y43.3 Adverse effects in therapeutic use, antineoplastic products or drugs
Y63.2 Failure in dosage, overdose of radiation given during therapy
Y84.2 Abnormal reaction, radiological procedure and radiotherapy

^ World Health Organization. International Statistical Classification of Diseases and Related Health problems, Tenth Revision. Geneva: World Health Organization. 2007